Almac Group Implements Continuous Flow Expertise at Global HQ

News
Article

Almac Sciences has announced the expansion of its technology capabilities within its API services and chemical development portfolio through implementation of continuous flow expertise.

Member of the Almac Group, Almac Sciences, has announced the expansion of its technology capabilities within its API services and chemical development portfolio through implementation of continuous flow expertise at its headquarters in the United Kingdom.

In a Jan. 7, 2019 press release, the company revealed that in addition to implementing continuous flow expertise, it will also introduce flow capacity within Arran Chemical Company, which is based in Ireland. These expanded capabilities form part of Almac Sciences four-year strategy, which is aimed at the development of Flow Assisted Synthesis Technology (FAST).

FAST will be focused on four key areas: high-pressure hydrogenations; high energy chemistry; oxidation; and photo-redox light emitting diode mediated chemistries. In support of this strategy, Innovate UK has awarded Almac Sciences with a Knowledge Transfer Partnership for the development of novel routes to chiral amines using flow technology. Further to this, Arran Chemical Company, in a joint effort with Queen’s University, Belfast, has secured a Horizon 2020-funded program to support four PhD studentships from 2019 for four years in line with the FAST strategy.

Prof. Tom Moody, VP Technology Development & Commercialization, Almac & Arran Chemical Company commented, “The introduction of continuous flow technology further enhances Almac Sciences’ capabilities within API development and manufacture. Flow technology is highly flexible, robust, economic, and regarded as the most exciting and innovative growth technology for the preparation of APIs. We are delighted to now offer this within our portfolio and will strive to continue providing world-class solutions to advance human health globally.”

Source: Almac Group

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content